E-Paper | March 17, 2026

European drug regulator recommends AstraZeneca's Covid drug

Published March 24, 2022
comments
Whatsapp Channel

The European Medicines Agency has authorised the use of AstraZeneca Plc's antibody drug for preventing Covid-19 infections in adults and adolescents over 12 years of age, reports Reuters.

The treatment is meant for adults whose immune system is too weak to respond to vaccines and offers a new tool to ease the pandemic burden on healthcare systems.

The recommendation by the European Medicines Agency (EMA) is set to be confirmed swiftly by the European Commission, which has the final word on market access.

Live Coronavirus

Read more

Most Popular

01
02
03
04
05
06
07
08
09

Latest Stories

Opinion

Editorial

Holding the line
16 Mar, 2026

Holding the line

PAKISTAN’S long battle against polio has recently produced encouraging signs. Data from the national eradication...
Power self-reliance
Updated 16 Mar, 2026

Power self-reliance

PAKISTAN’S transition to domestic sources of electricity is a welcome development for a country that has long been...
Looking for safety
16 Mar, 2026

Looking for safety

AS the Middle East conflict enters its third week, the war’s most enduring victims are not those who wage it....
Battling hate
Updated 15 Mar, 2026

Battling hate

In the current scenario, geopolitical conflict, racial prejudice and religious bigotry all contribute to the threats Muslims face.
TB drugs shortage
15 Mar, 2026

TB drugs shortage

‘CRIMINAL negligence’ is the phrase that jumps to mind when one considers the disturbing consequences of the...
Chinese diplomacy
Updated 14 Mar, 2026

Chinese diplomacy

THERE are signs that China is taking a more active role in trying to resolve the issue of cross-border terrorism...
Dawn News English
Subscribe